Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
Eli Lilly's Ebglyss improves skin and itch symptoms in eczema patients, including Dupixent-treated cases, with positive Phase ...
Sanofi shares rise as Q3 results beat forecasts on vaccines and Beyfortus sales
Sanofi (EPA:SASY) shares rose on Friday after the pharmaceutical giant posted better-than-expected third-quarter results, ...
The Pharma Letter15h
Positive results for J&J’s Tremfya in plaque psoriasis
Treatment with Tremfya (guselkumab) resulted in clear or almost clear skin in the majority of adults with low body surface ...
The Pharma Letter15h
Lilly's Ebglyss demonstrated meaningful improvement in eczema
New results show Eli Lilly Ebglyss (lebrikizumab-lbkz) improved skin (including hand and face) and itch among patients with ...
Real Simple on MSN12h
Dermatologists Have Spoken: These Are the 10 Products You Need to Winterize Your Skincare Routine
And while we often feel the dryness on our face first, our hands and legs experience it, too, shares Dr. Azadeh Shirazi, ...
Indiatimes9h
Sanofi India Share Price
Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2023.For the quarter ...